Tech Company Inital Public Offerings
Sensei Biotherapeutics IPO
Sensei Biotherapeutics, based in Rockville, debuted as a public company on 2/4/2021.
Transaction Overview
Company Name
Announced On
2/4/2021
Transaction Type
IPO
Amount
$100,050,000
Proceeds Purpose
Use of proceeds for the Sensei Biotherapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1405 Research Blvd. 125
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
Sensei Biotherapeutics is a clinical-stage biotechnology company developing novel biologics therapies targeting key components of the immune system for the treatment of cancers of unmet need. Driven by innovative science, world class scientists, and an entrepreneurial culture.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Celebi
Chief Medical Officer
Marie Fjaellskog
Chief Scientific Officer
Robert Pierce
Vice President
Jean Campbell
Vice President
Edward van der Horst
VP - Finance
Erin Colgan
VP - Operations
Pauline Callinan
VP - Operations
Alice Drumheller
Browse more venture capital transactions:
Prev: 2/4/2021: SpectraWAVE venture capital transaction
Next: 2/4/2021: Leadspace venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs